Merck hikes revenue outlook as new drug sales grow, but cuts profit guidance due to deal charges
CNBC
Read Full Article at CNBC →Ad Slot — In-Article (728x90)
Merck cut its profit guidance due to a charge tied to its acquisition of biotech company Terns Pharmaceuticals.
This is a summary. For the full story, read the original article at CNBC.
Original source: CNBC